Deer Velvet Harvesting: Welfare Considerations in Farming Practice

Velvet antler — the soft, vascularised growth phase of deer antlers — is harvested in New Zealand, China, Russia, and other countries for use in traditional medicine and health supplements. The welfare implications of velvet removal, which is performed while the antler is still live tissue, are significant.

Key Facts

New Zealand is the world's largest producer of velvet antler, producing approximately 500 tonnes annually from farmed red deer and elk (wapiti)
Velvet antler is harvested annually from male deer during the rapid spring growth phase; the antler at this stage contains nerves, blood vessels, and cartilage — it is live, innervated tissue
In New Zealand, velvet removal must be performed under veterinary supervision using local anaesthetic — a welfare standard not present in many other producing countries
Without anaesthetic, velvet harvesting causes significant pain: animals in unsedated harvesting show acute stress responses, vocalisation, and attempted escape
The Chinese velvet antler industry — the world's second largest — operates largely without mandatory anaesthetic requirements; welfare standards are extremely variable
Velvet antler is marketed as a supplement for joint health, athletic performance, and various health claims; the scientific evidence for most claimed benefits is weak or insufficient
Deer used for velvet harvesting must be regularly handled — a significant source of stress for prey species with strong flight responses, even in farm-accustomed animals

Welfare Considerations

Velvet harvesting without anaesthesia causes acute pain: the velvet is innervated tissue, and its removal without pain relief is comparable to surgical amputation without anaesthesia. New Zealand's requirement for veterinary-administered local anaesthetic represents a genuine welfare advance, but it applies only to New Zealand production. Global velvet antler products — particularly those from China, Korea, and Russia — may be produced without pain relief, making the welfare implications of purchasing these products significant. Beyond the harvest event itself, deer on velvet farms experience regular stressful handling — a welfare cost that accumulates across the animal's production life. The health benefit claims that motivate the market are largely unsupported by clinical evidence, meaning there is limited justification for the welfare cost beyond cultural and market tradition.

What You Can Do

Avoid purchasing velvet antler supplements or products from supply chains without documented anaesthetic requirements during harvesting
Be sceptical of health claims about velvet antler — most are poorly supported by clinical evidence
Support welfare reform in global velvet antler production through campaigns for international standards requiring anaesthetic during harvesting
If purchasing New Zealand velvet products, verify they were produced under New Zealand's veterinary supervision requirements
Support research into alternative treatments for joint health and other conditions marketed with velvet antler, reducing demand for products with welfare costs